Report initial data for the SG-001 program
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 6 Aug 2025
- Due
- 31 Dec 2025
- Checked
- 2 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“SG-001 Program on Track for Initial Data Readout in 2025.”
What we found
Evidence strength A What the grades mean
The company did not report initial data for SG-001 in 2025; subsequent filings indicate the program is still in the animal study phase with a pre-IND submission anticipated in 2026.
-
A Adma Biologics, Inc. 8-K filed 2026-01-12
“Advancing SG-001 Pipeline Program with Anticipated FDA Pre-IND Submission in 2026” ✓ confirmed on the page
-
A Adma Biologics, Inc. 10-K filed 2026-02-25
“We are currently conducting animal studies for SG-001, and anticipate submitting a pre-IND package to the FDA in fiscal year 2026” ✓ confirmed on the page
Market reaction: the shares moved +2.4% against the S&P 500 over the three sessions around the disclosure (9 Jan 2026 to 14 Jan 2026). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- SG-001 initial data readout
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: disagreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and read it as “no_evidence”, so a person decides.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Adma Biologics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-ADMA-003438 · Corrections policy